Mark L Smith

Title: The Innovative Contributions of Mark L. Smith

Introduction

Mark L. Smith is a notable inventor based in Davis, California, recognized for his significant contributions to the field of vaccine technology. With a total of three patents to his name, Smith has developed innovative methods that enhance vaccine assembly and delivery.

Latest Patents

Among his latest patents is a flexible vaccine assembly and delivery platform. This invention describes various methods for creating vaccines using re-assembled virus-like particles (VLPs). The process begins with disassembling the VLPs into encapsidation intermediate populations. Each population undergoes chemical conjugation of unique peptide or nucleic moieties, forming separate groups. A predetermined amount of these different encapsidation intermediates is then mixed and joined to create intact VLPs that encapsulate a nucleic acid core. This innovative approach allows the reassembled VLP to display multiple peptides or nucleic acids, with the nucleic acid serving as a scaffold or engineered for the expression of an immunomodulatory protein in eukaryotic cells.

Another significant patent involves plant virus coat fusion proteins with GDF8 epitopes. This invention provides a fusion protein that combines a plant virus coat protein with a GDF8 peptide domain or its antigenic fragment. The patent also includes plant virus vectors that express this fusion protein and methods for utilizing these vectors.

Career Highlights

Mark L. Smith has worked with several prominent companies in the biotechnology sector, including Kentucky Bioprocessing, Inc. and Schering-Plough Animal Health Corporation. His experience in these organizations has contributed to his expertise in vaccine development and bioprocessing.

Collaborations

Throughout his career, Smith has collaborated with notable professionals in the field, including Kenneth E. Palmer and John A. Lindbo. These collaborations have further enriched his research and development efforts.

Conclusion

Mark L. Smith's innovative work in vaccine technology exemplifies the impact of dedicated inventors in advancing public health. His patents reflect a commitment to improving vaccine delivery systems and enhancing immunological responses.